MAPT and Alzheimer disease: Thus, numerous efforts are now exploiting cerebrospinal fluid analysis (CSF)4 and cutting-edge diagnostic neuroimaging techniques5, for the detection of the presence of Aβ and/or tau protein aggregates in living AD patients.